Works matching Bristol-Myers Co.

Results: 640

BRISTOL-MYERS SQUIBB Co. v. PHARMACHEMIE B. V 361 F3d 1343 (Fed. Cir.), rehearing en banc denied, 2004 U.S. App. LEXIS 10300 (Fed. Cir. Apr. 21, 2004).

Published in:: Berkeley Technology Law Journal, 2005, v. 20, n. 1, p. 174
Publication type:: Article

MAINTAINING DUE PROCESS BY EXTENDING BRISTOL-MYERS SQUIBB CO. TO FEDERAL CLASS ACTIONS.

Published in:

American University Law Review, 2023, v. 73, n. 1, p. 293

By:

SYCH, FELICIA D.

Publication type:

Article

BRISTOL-MYERS SQUIBB CO. v. SUPERIOR COURT: REPROACHING THE SLIDING SCALE APPROACH FOR THE FIXABLE FAULT OF SLIDING TOO FAR.

Published in:

Maryland Law Review, 2018, v. 77, n. 3, p. 862

By:

FELICCIA, JOHN V.

Publication type:

Article

Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County: AN EXPLORATION OF THE "ARISES OUT OF" PRONG IN PERSONAL JURISDICTION.

Published in:

Mississippi College Law Review, 2019, v. 37, n. 3, p. 245

By:

Walker, Loden

Publication type:

Article

A Mild and Efficient Synthesis of Oxindoles: Progress Towards the Synthesis of Welwitindolinone A Isonitrile ( We gratefully acknowledge financial support from Yamanouchi, Merck, Pfizer, and Amgen. J.M.R. is the recipient of an NIH postdoctoral fellowship. K.R. thanks Sankyo Co., LTD.; M.H. thanks Daiso Co., LTD., M.M.W. thanks Bristol Myers Squibb for a graduate fellowship. )

Published in:

Angewandte Chemie, 2004, v. 116, n. 10, p. 1290

By:

Joseph M. Ready;
Sarah E. Reisman;
Makoto Hirata;
Matthew M. Weiss;
Kazuhiko Tamaki;
Timo V. Ovaska;
John L. Wood

Publication type:

Article

A Mild and Efficient Synthesis of Oxindoles: Progress Towards the Synthesis of Welwitindolinone A Isonitrile ( We gratefully acknowledge financial support from Yamanouchi, Merck, Pfizer, and Amgen. J.M.R. is the recipient of an NIH postdoctoral fellowship. K.R. thanks Sankyo Co., LTD.; M.H. thanks Daiso Co., LTD., M.M.W. thanks Bristol Myers Squibb for a graduate fellowship. )

Published in:

Angewandte Chemie International Edition, 2004, v. 43, n. 10, p. 1270, doi. 10.1002/anie.200353282

By:

Joseph M. Ready;
Sarah E. Reisman;
Makoto Hirata;
Matthew M. Weiss;
Kazuhiko Tamaki;
Timo V. Ovaska;
John L. Wood

Publication type:

Article

BRISTOL-MYERS SQUIBB CO. V. SUPERIOR COURT OF CALIFORNIA, SAN FRANCISCO COUNTY, ET AL: A DEATH KNELL FOR NATIONWIDE CLASS ACTIONS?

Published in:

University of Cincinnati Law Review, 2018, v. 87, n. 3, p. 829

By:

McClellan, Annie

Publication type:

Article

Access to hepatitis C medicines.

Published in:

Bulletin of the World Health Organization, 2015, v. 93, n. 11, p. 799, doi. 10.2471/BLT.15.157784

By:

Edwards, Danny J.;
Coppens, Delphi G. M.;
Prasad, Tara L.;
Rook, Laurien A.;
Iyera, Jayasree K.

Publication type:

Article

PRESCRIBING UPDATE.

Published in:: Patient Care (Print), 2002, v. 36, n. 13, p. 14
Publication type:: Article

Genetics institute opens in Strasbourg.

Published in:: Nature, 1994, v. 372, n. 6502, p. 120, doi. 10.1038/372120b0
Publication type:: Article

PERSONAL JURISDICTION AND ALIENS.

Published in:

Michigan Law Review, 2018, v. 116, n. 7, p. 1205, doi. 10.36644/mlr.116.7.personal

By:

Dodge, William S.;
Dodson, Scott

Publication type:

Article

ONS Gears Up for Bristol-Myers Squibb Tour of Hope™.

Published in:: ONS News, 2004, v. 19, n. 9, p. 9
Publication type:: Article

Out of the Quandary: Personal Jurisdiction Over Absent Class Member Claims Explained.

Published in:

Review of Litigation, 2019, v. 39, n. 1, p. 31

By:

Spencer, A. Benjamin

Publication type:

Article

THE CLASS ACTION STRUGGLE: SHOULD BRISTOLMYERS’S LIMIT ON PERSONAL JURISDICTION APPLY TO CLASS ACTIONS?

Published in:

Emory Law Journal, 2021, v. 71, n. 2, p. 325

By:

Mikuta, John

Publication type:

Article

New Science: Promising Treatment Options for Metastatic Breast Cancer.

Published in:

2009

By:

Skripac, Tracy

Publication type:

Proceeding

Of cactuses and cures.

Published in:: Frontiers in Ecology & the Environment, 2005, v. 3, n. 10, p. 572, doi. 10.1890/1540-9295(2005)003[0572:OCAC]2.0.CO;2
Publication type:: Article

The 2005 Tour of Hope.

Published in:: Nursing Education Perspectives (National League for Nursing), 2005, v. 26, n. 5, p. 322
Publication type:: Article

New molecular entity.

Published in:: 2009
Publication type:: Product Review

FDA actions in brief.

Published in:: Formulary, 2008, v. 43, n. 6, p. 189
Publication type:: Article

New molecular entities.

Published in:: 2007
Publication type:: Product Review

FDA actions in brief.

Published in:: Formulary, 2007, v. 42, n. 6, p. 362
Publication type:: Article

New indications.

Published in:: 2006
Publication type:: Product Review

MISGUIDED PANIC AND MISSED OPPORTUNITY FOR PHARMACEUTICAL INVENTIONS: HOW UNEXPECTED RESULTS ECLIPSED REASONABLE EXPECTATION OF SUCCESS IN BMS V. TEVA.

Published in:

Berkeley Technology Law Journal, 2016, v. 31, p. 587, doi. 10.15779/Z38C85X

By:

Pride, Christelle K.

Publication type:

Article

NEW Products.

Published in:: 2008
Publication type:: Product Review

NEW PRODUCTS.

Published in:: 2006
Publication type:: Product Review

lpilimumab.

Published in:: 2011
Publication type:: Product Review

Apixaban.

Published in:: 2011
Publication type:: Product Review

Saxagliptin.

Published in:: Australian Prescriber, 2011, v. 34, n. 3, p. 89
Publication type:: Article

Labeling changes issued for antibiotic used in UTIs.

Published in:: Urology Times, 2006, v. 34, n. 4, p. 6
Publication type:: Article

Injectable antibiotic treats UTIs.

Published in:: Urology Times, 1997, v. 25, n. 1, p. 44
Publication type:: Article

Immunotherapy's cancer remit widens.

Published in:

Nature, 2013, v. 497, n. 7451, p. 544, doi. 10.1038/staging_green_ontol_497544a

By:

Ledford, Heidi

Publication type:

Article

Seven days: 24-30 August 2012.

Published in:: Nature, 2012, v. 488, n. 7413, p. 562, doi. 10.1038/488562a
Publication type:: Article

Company Performance Roundup.

Published in:

Business & Society Review (00453609), 1992, n. 82

By:

Moskowitz, Milton R.

Publication type:

Article

The Clinical Lipid Specialist.

Published in:: JAMA: Journal of the American Medical Association, 1990, v. 264, n. 14, p. 1870
Publication type:: Article

PHARMACY CORNER.

Published in:: Oncology Nursing Forum, 2000, v. 27, n. 3, p. 549
Publication type:: Article

Abilify approved by the US FDA for add-on treatment of major depressive disorder.

Published in:: Expert Review of Neurotherapeutics, 2008, v. 8, n. 1, p. 7
Publication type:: Article

Movers & Shakers.

Published in:: Chemistry & Industry, 2015, v. 79, n. 4, p. 30, doi. 10.1002/cind.794_8.x
Publication type:: Article

Direct-to-Consumer Advertising and the Demise of the Ideal Model of Health Care.

Published in:

Independent Review, 2006, v. 11, n. 2, p. 223

By:

White, Ronald F.

Publication type:

Article

THE WEATHERVANE.

Published in:: Hawaii Journal of Medicine & Public Health, 2013, v. 72, n. 1, p. 34
Publication type:: Article

Stavudine: neuromuscular weakness.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 29
Publication type:: Article

Oncology Update.

Published in:

2009

By:

Smart, Michael

Publication type:

Product Review

Corporate Sponsors of the XlVth International Congress of Nephrology/Association Sponsors of the XIVth International Congress of Nephrology.

Published in:: Kidney International, 1996, v. 50, n. 6, p. 2145, doi. 10.1038/ki.1996.543
Publication type:: Article

US FDA Clears Bristol-Myers New Drug for Chronic Hepatitis B.

Published in:: Clinical Infectious Diseases, 2005, v. 40, n. 10, p. 1
Publication type:: Article

Barr Says FDA Approves Generic Version of Anti-HIV Drug.

Published in:: Clinical Infectious Diseases, 2005, v. 40, n. 2, p. 1
Publication type:: Article

GILEAD, MERCK, BRISTOL-MYERS TO COMBINE HIV DRUGS.

Published in:: Clinical Infectious Diseases, 2004, v. 39, n. 1, p. iv
Publication type:: Article

Verify, Then Trust: How to Legalize Off-Label Drug Marketing.

Published in:

Penn State Law Review, 2012, v. 117, n. 2, p. 407

By:

Khan, Fazal;
Holloway, Justin

Publication type:

Article

TOO BIG FOR PERSONAL JURISDICTION? A PROPOSAL TO HOLD COMPANIES ACCOUNTABLE FOR IN-STATE CONDUCT IN ACCORDANCE WITH DUE PROCESS PRINCIPLES.

Published in:

Cardozo Law Review, 2019, v. 40, n. 3, p. 1367

By:

Pristupa, Polina

Publication type:

Article

Bristol-Myers Squibb closing Cruiserath site.

Published in:: TCE: The Chemical Engineer, 2014, n. 874, p. 17
Publication type:: Article

Biomedical briefing.

Published in:: Nature Medicine, 2012, v. 18, n. 8, p. 1162, doi. 10.1038/nm0812-1162
Publication type:: Article

New diabetes drugs go beyond insulin to flush out excess sugar.

Published in:

Nature Medicine, 2011, v. 17, n. 6, p. 636, doi. 10.1038/nm0611-636a

By:

Heger, Monica

Publication type:

Article